Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04753216
Status:
COMPLETED
Last Update Posted:
2023-01-19
First Post:
2021-02-10
Brief Title:
Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant Recurrent or Refractory Ovarian Fallopian Tube or Primary Peritoneal Cancer
Sponsor:
Organization:
Northwestern University